1.53
price down icon3.16%   -0.05
after-market After Hours: 1.55 0.02 +1.31%
loading
Hoth Therapeutics Inc stock is traded at $1.53, with a volume of 715.63K. It is down -3.16% in the last 24 hours and down -4.38% over the past month. Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
See More
Previous Close:
$1.58
Open:
$1.58
24h Volume:
715.63K
Relative Volume:
0.67
Market Cap:
$20.29M
Revenue:
-
Net Income/Loss:
$-7.51M
P/E Ratio:
-1.1591
EPS:
-1.32
Net Cash Flow:
$-8.02M
1W Performance:
+0.00%
1M Performance:
-4.38%
6M Performance:
+91.06%
1Y Performance:
+103.73%
1-Day Range:
Value
$1.5001
$1.5999
1-Week Range:
Value
$1.46
$1.78
52-Week Range:
Value
$0.6506
$3.80

Hoth Therapeutics Inc Stock (HOTH) Company Profile

Name
Name
Hoth Therapeutics Inc
Name
Phone
(646)756-2997
Name
Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
HOTH's Discussions on Twitter

Compare HOTH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HOTH
Hoth Therapeutics Inc
1.53 20.95M 0 -7.51M -8.02M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-15-19 Initiated The Benchmark Company Speculative Buy

Hoth Therapeutics Inc Stock (HOTH) Latest News

pulisher
11:58 AM

Chart based analysis of Hoth Therapeutics Inc. trendsEntry Point & Smart Investment Allocation Insights - newser.com

11:58 AM
pulisher
10:31 AM

Can momentum traders help lift Hoth Therapeutics Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - newser.com

10:31 AM
pulisher
09:06 AM

Will Hoth Therapeutics Inc. stock maintain growth storyStop Loss & Free Weekly Watchlist of Top Performers - newser.com

09:06 AM
pulisher
09:01 AM

Measuring Hoth Therapeutics Inc.’s beta against major indicesJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com

09:01 AM
pulisher
08:05 AM

What candlestick patterns are forming on Hoth Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com

08:05 AM
pulisher
Oct 12, 2025

How to forecast Hoth Therapeutics Inc. trends using time seriesMarket Rally & Reliable Breakout Forecasts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Is Hoth Therapeutics Inc. stock entering bullish territoryJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What valuation multiples suggest for Hoth Therapeutics Inc. stockMarket Movers & Fast Entry Momentum Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What analysts say about Hoth Therapeutics Inc stockSector ETF Performance & Free High Yield Growth Strategies - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics shares climb after expanding AI partnership with NVIDIA - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics rises as it expands AI push with Nvidia licenses - TradingView

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics expands AI capabilities with NVIDIA partnership By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics expands artificial intelligence initiative, selects NVIDIA AI Enterprise platform - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics expands AI capabilities with NVIDIA partnership - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform - MarketScreener

Oct 08, 2025
pulisher
Oct 07, 2025

Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025 - WV News

Oct 07, 2025
pulisher
Oct 06, 2025

Analyzing Hoth Therapeutics Inc. with multi timeframe chartsVolume Spike & Community Verified Swing Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Best data tools to analyze Hoth Therapeutics Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention - ADVFN

Oct 05, 2025
pulisher
Oct 02, 2025

EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris PharmaResearchAndMarkets.com - The AI Journal

Oct 02, 2025
pulisher
Oct 02, 2025

About Us - FinancialContent

Oct 02, 2025
pulisher
Sep 28, 2025

Is Hoth Therapeutics Inc a good long term investmentCandlestick Pattern Analysis & Free Exceptional Risk Adjusted Gains - earlytimes.in

Sep 28, 2025
pulisher
Sep 26, 2025

What institutional flow reveals about Hoth Therapeutics Inc.Portfolio Value Summary & High Yield Stock Recommendations - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart.com

Sep 26, 2025
pulisher
Sep 25, 2025

Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com Nigeria

Sep 25, 2025
pulisher
Sep 24, 2025

Hoth expands HT-001 development with patents for cancer therapy side effects By Investing.com - Investing.com South Africa

Sep 24, 2025
pulisher
Sep 24, 2025

Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities - WV News

Sep 24, 2025
pulisher
Sep 23, 2025

Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance

Sep 23, 2025
pulisher
Sep 20, 2025

Chart Watch: Can Hoth Therapeutics Inc stock double in the next year2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Bull Run: Will Hoth Therapeutics Inc benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

New Highs: Whats the MACD signal for Hoth Therapeutics IncWeekly Trend Recap & Proven Capital Preservation Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Risks Report: Whats the outlook for Hoth Therapeutics Incs sectorWeekly Trading Summary & Daily Price Action Insights - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Market Review: Is NGVT a momentum stockMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com

Sep 18, 2025

Hoth Therapeutics Inc Stock (HOTH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):